Status:
COMPLETED
Accupressure of P6 to Reduce Nausea During Cesarean Section
Lead Sponsor:
Northwestern University
Conditions:
Pregnancy Related
Cesarean Delivery
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate if the addition of P6 pressure point stimulation as opposed to sham-point stimulation will decrease intraoperative and postoperative nausea and vomiting (IONV ...
Detailed Description
After obtaining written informed consent from the subject. They were then randomized to either the P6 acupressure or a sham acupressure group. Envelopes containing group assignment information were pr...
Eligibility Criteria
Inclusion
- ≥18 years of age
- English-speaking
- Pregnant patients presenting for scheduled cesarean delivery of a full-term fetus (\>37 weeks' gestation)
- Patients scheduled as ERAC
- Parturients undergoing spinal anesthesia
Exclusion
- Patients requiring emergent delivery,
- Fetal demise
- Patients with adhesive allergy/sensitivity
- Patients with allergy/sensitivity to nickel,
- Patients with inability to consent,
- Patients with known abnormal placentation
- Patients with pacemakers/defibrillators
- Patients with positive COVID-19 tests
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04799587
Start Date
May 26 2021
End Date
September 30 2023
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611